Clinical trials · Portland, OR
Acute Myeloid Leukemia Post Cytotoxic Therapy clinical trials in Portland
We’re tracking 6 recruiting acute myeloid leukemia post cytotoxic therapy studies with a site in or near Portland — including Phase 1, Phase 1/Phase 2, Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Portland
- NCT03471260RecruitingPhase 1/Phase 2
Ivosidenib and venetoclax for IDH1-mutated leukemia or MDS
This Phase 1/2 study tests whether the medicines ivosidenib and venetoclax (with or without azacitidine) can help people with certain “IDH1-mutated” blood cancers like AML or high-risk MDS. It’s meant for patients whose disease has come back, doesn’t respond, or who can’t safely get standard chemotherapy.
Portland, OregonAges 18 years+ - NCT05554406RecruitingPhase 2
New drug therapy for high-risk AML
This trial is testing new drug combinations for people with newly diagnosed, high-risk AML who have not yet started treatment. It aims to find more effective therapies for this aggressive form of leukemia.
Portland, OregonAges 18–59 - NCT05564390RecruitingPhase 2
MyeloMATCH screening to match you to AML or MDS treatment
This study screens people with newly suspected acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) to see which treatment approach fits best—either a specific study treatment or standard care. It may help by directing you to the right option and by sharing your blood/bone marrow samples for research.
Portland, OregonAges 18 years+ - NCT06950034RecruitingPhase 1
Testing STX-0712 for advanced CMML or AML
This early-phase study tests a new drug called STX-0712 for people with certain types of blood cancers (CMML or AML) that have not responded to standard treatments. The goal is to see if the drug is safe and can help shrink or control the cancer.
Portland, OregonAges 18 years+ - NCT05183035RecruitingPhase 3
Testing venetoclax for children with relapsed AML
This study tests a drug called venetoclax in children and young adults whose acute myeloid leukemia (AML) has returned after treatment. The drug may help block cancer cell growth. The study also looks at safety and how well the drug works when given alone or with other treatments.
Portland, OregonAges 4 weeks–21 years - NCT04726241RecruitingPhase 1/Phase 2
Testing blood and bone marrow samples in young leukemia patients
This trial looks at blood and bone marrow samples from children and teens whose leukemia has come back or is hard to treat. The goal is to better understand the disease and guide future options for these patients.
Portland, OregonAges Up to 22 years
Hear when a new Acute Myeloid Leukemia Post Cytotoxic Therapy trial opens near Portland, OR
We’ll email you when one opens near Portland, OR — at most once a week, no account needed, unsubscribe anytime.
Acute Myeloid Leukemia Post Cytotoxic Therapy trials in other cities
Where these studies are running near Portland
Institutions with a site for the recruiting acute myeloid leukemia post cytotoxic therapy studies listed above.
- Oregon Health and Science University · 5 studies
- Providence Portland Medical Center · 2 studies
- Providence Saint Vincent Medical Center · 2 studies
- Doernbecher Children's Hospital
- Legacy Emanuel Hospital and Health Center
- Providence Newberg Medical Center
- Providence Willamette Falls Medical Center
What taking part in a acute myeloid leukemia post cytotoxic therapy study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting acute myeloid leukemia post cytotoxic therapy studies in Oregon.
Common questions
- Are there acute myeloid leukemia post cytotoxic therapy clinical trials near Portland?
- Yes. We're currently tracking 6 recruiting acute myeloid leukemia post cytotoxic therapy studies with a site near Portland, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a acute myeloid leukemia post cytotoxic therapy study near Portland?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Portland to take part?
- Not necessarily. These studies have a site near Portland, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a acute myeloid leukemia post cytotoxic therapy trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New acute myeloid leukemia post cytotoxic therapy studies open near Portland regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.